Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU

  • Read more about Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU

Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents

  • Read more about Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents

Objective Evaluation of the Effect of Oculoplastic Operations Using the Vectra M 3D Imaging System

  • Read more about Objective Evaluation of the Effect of Oculoplastic Operations Using the Vectra M 3D Imaging System

Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children

  • Read more about Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children

Modified Thoracoabdominal Nerve Block(M-TAPA) in Pediatric Laparoscopic Appendectomies

  • Read more about Modified Thoracoabdominal Nerve Block(M-TAPA) in Pediatric Laparoscopic Appendectomies

A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA)

  • Read more about A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA)

Cognitive Impairment and Fatigue After Mild to Moderate COVID-19

  • Read more about Cognitive Impairment and Fatigue After Mild to Moderate COVID-19

SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

  • Read more about SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Moderators and Mediators (M & M Trial) of Psychosocial Treatments of Chronic Pain

  • Read more about Moderators and Mediators (M & M Trial) of Psychosocial Treatments of Chronic Pain

Evaluation of Autogenous Demineralized Dentin Graft Vs Autogenous Bone Graft in Management of Intrabony Defects

  • Read more about Evaluation of Autogenous Demineralized Dentin Graft Vs Autogenous Bone Graft in Management of Intrabony Defects

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 90
  • Page 91
  • Page 92
  • Page 93
  • Current page 94
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA